EBV reactivation in a patient undergoing chemotherapy for invasive thymoma;Riattivazione di EBV in un paziente sottoposto a chemioterapia per metastasi da timoma misto invasivo

Infezioni in Medicina

Volumn 15, Issue 3, 2007, Pages 195-198

  Giordano, Salvatore ^a   Pampinella, Diego ^b   Alù, Massimiliano ^a   Agostara, Biagio ^a   Romano, Amelia ^a  

^a ARNAS Civico Palermo   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Epstein Barr virus; Immunocompromised; Reactivation; Thymoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN G;

ARTICLE; EPSTEIN BARR VIRUS; HERPES VIRUS; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; PAROTID GLAND DISEASE; PLEURA METASTASIS; POLYMERASE CHAIN REACTION; THYMOMA; VIRUS ACTIVATION;

ANTINEOPLASTIC AGENTS; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PAROTITIS; THYMOMA; THYMUS NEOPLASMS;

EID: 35948996595     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Croen K.D. Latency of the human herpes viruses. Ann. Rev. Med. 42, 61-67, 1991.
2. Black F.L., Woodall J.P., Evans A.S., Liebhaber H., Herde G. Prevalence of antibody against viruses in the Tiriyo, an isolated Amazon tribe. Am. J. Epidemiol. 91, 430-438, 1970.
3. Peter J., Ray C.G. Infectious mononucleosis. Pediatr. Rev. 19, 276-279, 1998.
4. Kieff E., Rickinson A.B. Epstein-Barr virus and its replication. In: Knipe D.M., Howley P.M. eds. Fields Virology. 4th Ed. Philadelphia: Lippincott Williams & Wilkins, 2001; 2511-73.
5. Rickinson A.B., Kieff E. Epstein-Barr virus. In: Knipe D.M., Howley P.M. eds. Fields Virology. 4th Ed. Philadelphia: Lippincott Williams & Wilkins, 2001, 2575-2627.
6. Liebowitz D., Kieff E. Epstein-Barr virus. In: The Human Herpesviruses, Edited by Roizman B, Whitley R., Lopez C., New York, Raven Press, 1993, p.107.
7. Epstein M.A., Barr Y.M., Achong B.G. Studies with Burkitt's lymphoma. Wistar Inst. Symp. Monogr. 4, 69-82, 1965.
8. Andersson-Anvret M., Forsby N., Klein G., Henle W. Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination. Int. J. Cancer 20, 486-494, 1977.
9. Nalesnik M.A., Makowka L., Starzl T.E. The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr. Probl. Surg. 25, 367-472, 1988.
10. Raab-Traub N., Rajadurai P., Flynn K., Lanier A.P. Epstein-Barr virus infection in carcinoma of the salivary gland. J. Virol. 65, 7032-7036, 1991.
11. Bonnet M, Guinebretiere J-M, Kremmer E, et al. Detection of Epstein-Barr virus in invasive breast cancers. J. Natl. Cancer Inst. 91, 1376-1381, 1999.
12. Sugarawa Y., Mizugaki Y., Uchida T., et al. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology 256, 196-202, 1999.
13. Leywraz S., Henle W., Chahinian A.P., et al. Association of Epstein-Barr virus with thymic carcinoma. New Engl. J. Med. 213, 1296-1299, 1985.
14. Silins S.L., Sculley T.B. Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4. Int. J. Cancer 60, 65-72, 1995.
15. Izumi K.M., Kaye K.M., Kieff E.D. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 94, 1447-1452, 1997.
16. Chen P.C., Pan C.C., Yang A.H., Wang L.S., Chiang H. Detection of Epstein-Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization. J. Pathol. 197, 5, 684-688 2002.
17. Morgan D.G., Niederman J.C., Miller G., Smith H.W., Dowaliby J.M. Site of Epstein-Barr virus replication in the oropharynx. Lancet 1, 2, 1154-1157, 1979.